1 / 8

What next?

What next?. Follow up research programs, astma & allergy, neurobehaviour Establish links to Policy Program Next cycle of the biomonitoring program Including emerging chemicals Focus on hot spots and specific cases eg social class etc Follow up of areas with deviating HBMvalues

ilana
Download Presentation

What next?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. What next? • Follow up research programs, astma & allergy, neurobehaviour • Establish links to Policy Program • Next cycle of the biomonitoring program • Including emerging chemicals • Focus on hot spots and specific cases eg social class etc • Follow up of areas with deviating HBMvalues • Enhance the participatory process: platform for priority setting • Raising awareness : pollution gets personal

  2. Follow-up research programs (health effects) • Neuro-psychological development of children • 209 children • 42 months • 4 areas (Rural, Non ferro, Waste incinerators, Harbours) Dr. M. Viaene- OPZ Geel • Asthma and allergy • 36 months • 145 children • 2 areas (Rural, Antwerp city) Prof K. Desager (UZA) & Dr. V. Nelen (PIH)

  3. Policy support • Follow-up programs (Policy support) • Multiphase approach • Phase 0: Identification of deviating HBM values; • Phase 1: Evaluation of the gravity of deviations with regard to seriousness and priority; • Phase 2: Identification of the cause of the deviation, potential sources • Phase 3: Proposal of policy and risk management options

  4. Descriptive statistics biom a rker Life style Decision moment 2 : Lo cal environmental problem ? guideli ne Is there for the N o biom a rker ? Uncertain Flemish Yes St e p 1 reference Yes, Guideline < lower level l ocal < lower level Yes No confidence confidence interval median source interval biomarker in area ? median St e p 3: Lo c al source biomarker in identification area? Decision moment 1 : via Seriousness - priorit y Acti on - Local Inventarisati on Yes environmental problem - I nternational comparison treshold - Modell ing : immission & - Epidemiological data exposure - Observed exposure - effect N o relationships STOP N o t Further consideration / relevant Decision moment 3: doubt Lo c al source ? Warning treshold Yes, Not enough No St e p 2: Cause ? I denti - evidence ficated Step 4 Step 4 Step 4 I n fluence of life Remedi Beha - further style? ation vioural research L o c al/ regional data : Questionnaire data advises - G eografi cal examination (clusters) - Contaminants elevated in: air , water, soil , nutrition ? - Questionnaire data on living environment/local food Communication with authorities Scenario for follow-up Decision moment 2: Local environmental problem? Decision moment 1: seriousness – prioritees Comparison with international data Epidemiological data Expsoure -effect Decision moment 3: Local source

  5. policy links • (B.S. 03-02-2004) Preventiedecreet Art 51 § 1 • The Flemish government: 1. Can set up a network for surveillance of exposure (measured in humans) and/or effects of exposure to physical and chemical factors in the population, with the intention to take measures to protect public health. 2. Takes at least measures for the development and execution of a program for biomonitoring. 3. Can - in execution of &1 - set up a fund (…). For this purpose a mandatory financial contribution can be imposed on industries or citizens that are responsible for the presence of physical or chemical factors harmful to health.

  6. Health in the centre of environmental policy Development of an environmental health care system monitoring Evaluation : action plan Follow up Remediation Advise Legal actions

  7. http://www.milieu-en-gezondheid.be Thanks to • 4400 participants • 26 maternities: midwaves, nurses, pediatricians, gynecologistsAlgemeen Medisch Labo (AML), Antwerpen • Schooldirectors and teachers, medical doctors and nurses from CLBs, • Community mayors and administrators • Bloodbank of the Red Cross -Bloedtransfusiecentrum O-Vlaanderen, Gent & Stamcellenbank, Hematologie – UZ Gasthuisberg, Leuven • Center for diagnosis of metabolic diseases : Antwerpen, Gent en Brugge • Kind en Gezin • Environmental health professionals

  8. Scientific partners • Coordination : Prof. G. Schoeters ( VITO) • Field work: Dr V. Nelen and E. Van de Mieroop • Statistics : Prof G. Molenberghs and L. Bruckers (UH) • Toxicology : Dr G. Koppen, Dr E. Den Hond, E . Brits (VITO) Prof . W. Baeyens (VUB), Prof N. Van Larebeke (U Ghent) • Astma and allergy: Prof K. Desager; Dr. V. Nelen • Food : Prof G. De Backer , Prof. Dehenauw, M. Bilau • Communication: Prof I. Loots; Prof L.Goorden; H. Keune;G. Nulens (UA) • Registers : Prof. Van loon; Dr. G. Van Kersschaver, C. Reynders • Environment and health admistration : D. Aerts, L. Casteleyn, • K. Van Campenhout • Health Administration : D. Wildemeersch, H. Chovanova

More Related